Phoenix, Arizona – May 7, 2024: The American Telemedicine Association (ATA) 2024 conference, held at the Phoenix Convention Center, saw ChoiceMMed, a subsidiary of Hongri Pharmaceuticals, present a range of groundbreaking health technology products. The annual ATA conference is the largest telemedicine and telehealth event globally, attracting healthcare professionals seeking cutting-edge solutions to improve healthcare delivery and reduce costs.
ChoiceMMed showcased its innovative card-sized multi-parameter detector, which combines multiple health monitoring functions, including cuffless blood pressure measurement, in a compact and portable design. The device's integration with health cloud services facilitates a seamless telemedicine ecosystem, enhancing remote health monitoring and management.
Visitors to the ChoiceMMed booth were impressed by the practicality and advanced features of the products, expressing keen interest in future collaborations. This enthusiastic response underscores the potential impact of ChoiceMMed's technology on the telemedicine and telehealth landscape.
ChoiceMMed showcased its innovative card-sized multi-parameter detector, which combines multiple health monitoring functions, including cuffless blood pressure measurement, in a compact and portable design. The device's integration with health cloud services facilitates a seamless telemedicine ecosystem, enhancing remote health monitoring and management.
Visitors to the ChoiceMMed booth were impressed by the practicality and advanced features of the products, expressing keen interest in future collaborations. This enthusiastic response underscores the potential impact of ChoiceMMed's technology on the telemedicine and telehealth landscape.
Under the guidance of Hongri Pharmaceuticals, ChoiceMMed continues to focus on technological innovation to address global health challenges and improve patient outcomes. The company remains committed to bringing health and well-being to more people through its advanced telemedicine solutions.
